Geron Stock (NASDAQ: GERN) stock price, news, charts, stock research, profile.
Open | $3.910 |
Close | - |
Volume / Avg. | 2.560M / 12.906M |
Day Range | 3.740 - 3.980 |
52 Wk Range | 1.640 - 4.300 |
Market Cap | $2.319B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 8.87% |
Days to Cover | 5.02 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Geron (NASDAQ: GERN) through any online brokerage.
Other companies in Geron’s space includes: Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), TG Therapeutics (NASDAQ:TGTX), PTC Therapeutics (NASDAQ:PTCT) and Agios Pharmaceuticals (NASDAQ:AGIO).
The latest price target for Geron (NASDAQ: GERN) was reported by Needham on Thursday, May 2, 2024. The analyst firm set a price target for 5.00 expecting GERN to rise to within 12 months (a possible 31.41% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Geron (NASDAQ: GERN) is $3.805 last updated Today at May 17, 2024 at 12:53 PM EDT.
There are no upcoming dividends for Geron.
Geron’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Geron.
Geron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.